Recovery Act Limited Competition: Research On Biosamples From Selected Diabetes Clinical Studies (RC4)

Post Date

January 4th 2010

Application Due Date

March 11th 2010

Funding Opportunity Number

RFA-OD-10-010

CFDA Number(s)

93.701

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Estimated Total Funding:

  $3000000

• Award Range:

  $None - $None

Grant Description

Purpose. This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery and Reinvestment Act of 2009 (Recovery Act or ARRA), Public Law 111-5, invites applicants to apply for: 1) Access to non-renewable (non- DNA) samples generated by selected NIDDK-funded clinical trials and studies and funding to perform validated laboratory assays on the requested samples; OR 2) To apply for funding for assays to be performed on non-renewable (non- DNA) samples generated by selected NIDDK-funded clinical trials and studies, with proof of access approved by the consortia. Samples and funding will not be provided for assay development or exploratory research with animal models, or any research utilizing samples other than those that derive from studies listed below. Investigators should propose to test scientifically meritorious hypotheses related to the clinical trial or studys goals, and within the intent of the signed consent form for each study or trial. Data generated under this FOA is expected to be returned to the consortium or NIDDK repository. Mechanism of Support. This FOA will utilize the RC4 grant mechanism. Funds Available and Anticipated Number of Awards. NIDDK intends to commit up to $3,000,000 under this FOA. We anticipate that 5-10 awards will be made for fiscal year 2010, pending the number and quality of applications and availability of funds.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-10-010.html